S. 2658 · 119th Congress

Medication Affordability and Patent Integrity Act

Introduced on Aug 1, 2025 by Margaret Wood Hassan (D-NH). One cosponsor. Latest action (Jul 28, 2026): Placed on Senate Legislative Calendar under General Orders. Calendar No. 528.

Stage
Reported by committee
Introduced
Aug 1, 2025
Cosponsors
1
1 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

A bill to require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.

Subjects

  • Drug safety, medical device, and laboratory regulation
  • Inflation and prices
  • Intellectual property
  • Manufacturing
  • Prescription drugs

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Margaret Wood HassanD-NHSponsor

Republicans · 1

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Aug 1, 2025Introduced in Senate
  2. Aug 1, 2025 · SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.
  3. Mar 19, 2026 · SenateCommittee on Health, Education, Labor, and Pensions. Hearings held.
  4. Jun 17, 2026 · SenateCommittee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
  5. Jul 28, 2026Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
  6. Jul 28, 2026 · SenateCommittee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
  7. Jul 28, 2026 · SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 528.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA8 reports
    $37M reported (all issues)
  2. BCBSM, Inc.4 reports
    $118K reported (all issues)
  3. BIOTECHNOLOGY INNOVATION ORGANIZATION4 reports
    $6.8M reported (all issues)
  4. Blue Cross and Blue Shield Association4 reports
    $5.1M reported (all issues)
  5. Blue Cross and Blue Shield of Florida, Inc.4 reports
    $380K reported (all issues)
  6. Campaign for Sustainable Drug Pricing (CSRxP)4 reports
    $200K reported (all issues)
  7. Fresenius Kabi4 reports
    $120K reported (all issues)Federal contractor: FRESENIUS KABI USA, LLCAI match · 99%
  8. GSK (fka GLAXOSMITHKLINE INC.)4 reports
    $5M reported (all issues)
  9. GUIDEWELL MUTUAL HOLDING CORPORATION4 reports
    $30K reported (all issues)
  10. JOHNSON & JOHNSON SERVICES, INC.4 reports
    $8.9M reported (all issues)
  11. VIATRIS INC.4 reports
    $2M reported (all issues)
  12. AMGEN INC.3 reports
    $5M reported (all issues)Federal contractor: AMGEN INC.AI match · 99%
  13. Pharmaceutical Industry Labor-Management Association3 reports
    $140K reported (all issues)
  14. AARP2 reports
    $7.9M reported (all issues)
  15. ASSOCIATION FOR ACCESSIBLE MEDICINES2 reports
    $1.7M reported (all issues)
  16. BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.2 reports
    $20K reported (all issues)
  17. Fresenius Kabi USA LLC2 reports
    $920K reported (all issues)Federal contractor: FRESENIUS KABI USA, LLCAI match · 100%
  18. The Campaign for Sustainable Rx Pricing2 reports
    $180K reported (all issues)
  19. AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)1 report
    $3M reported (all issues)
  20. American Society of Health-System Pharmacists1 report
    $260K reported (all issues)Federal contractor: AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS INC$350.5K in contracts, FY2026AI match · 100%
  21. Association of Accessible Medicines (formerly known as GPhA)1 report
    $60K reported (all issues)
  22. BLUE CROSS BLUE SHIELD OF MICHIGAN1 report
    $266K reported (all issues)
  23. Blood Cancer United (FKA The Leukemia & Lymphoma Society)1 report
    $590K reported (all issues)
  24. CENTER FOR INDIVIDUAL FREEDOM1 report
    $20K reported (all issues)
  25. COUNCIL FOR INNOVATION PROMOTION (C4IP)1 report
  26. Chamber of Commerce of the U.S.A.1 report
    $17M reported (all issues)
  27. EISAI INC.1 report
    $790K reported (all issues)Federal contractor: EISAI INC.AI match · 100%
  28. ELI LILLY AND COMPANY1 report
    Federal contractor: ELI LILLY AND COMPANY$286.4K in contracts, FY2026AI match · 100%
  29. INCYTE CORPORATION1 report
    $750K reported (all issues)
  30. INTELLECTUAL PROPERTY OWNERS ASSOCIATION1 report
    $50K reported (all issues)
  31. National Taxpayers Union1 report
    $30K reported (all issues)
  32. PFIZER INC.1 report
    $1.9M reported (all issues)Federal contractor: PFIZER INCAI match · 100%
  33. SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL)1 report
    $45K reported (all issues)
  34. Travere Therapeutics1 report
    $140K reported (all issues)Federal contractor: TRAVERE THERAPEUTICS, INC.$323.9K in contracts, FY2026AI match · 100%

Reports filed in 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.